ChemPartner PharmaTech Co.,Ltd. (SHE:300149)
China · Delayed Price · Currency is CNY 10.81
-0.37 (-3.31%)
At close: Apr 21, 2026
ChemPartner PharmaTech Market Cap
ChemPartner PharmaTech has a market cap or net worth of 5.38 billion as of April 21, 2026. Its market cap has increased by 70.32% in one year.
Market Cap
5.38B
Enterprise Value
5.47B
Revenue
1.07B
Ranking
n/a
PE Ratio
n/a
Stock Price
10.81
Market Cap Chart
Since December 22, 2010, ChemPartner PharmaTech's market cap has increased from 2.12B to 5.38B, an increase of 153.85%. That is a compound annual growth rate of 6.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 5.57B | 16.95% |
| Dec 31, 2025 | 4.76B | 49.45% |
| Dec 31, 2024 | 3.19B | -16.38% |
| Dec 29, 2023 | 3.81B | -26.51% |
| Dec 30, 2022 | 5.18B | -24.67% |
| Dec 31, 2021 | 6.88B | -6.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lifecome Biochemistry | 6.31B |
| Kexing Biopharm | 6.27B |
| Shenzhen Weiguang Biological Products | 6.21B |
| Shouyao Holdings (Beijing) Co., LTD. | 6.14B |
| Beijing Konruns Pharmaceutical | 6.14B |
| Novogene | 5.87B |
| Innovita Biological Technology | 5.85B |
| Wuhan Hvsen Biotechnology | 5.68B |